Literature DB >> 24080573

Integrating advances in insulin into clinical practice: Advances In insulin formulations.

Allen King1.   

Abstract

The central role of insulin in the management of patients with type 1 diabetes mellitus (T1DM) remains, nearly a century after its first use in humans. In patients with type 2 diabetes mellitus (T2DM), the role of insulin has evolved as other therapies have been introduced, with insulin now used across the spectrum of the disease. This article discusses the use of insulin in patients with T1DM or T2DM, including combined use with other agents in T2DM, with an emphasis on incretin-based therapies. In addition, new insulin products and concentrations are discussed along with their varied routes of administration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24080573

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  1 in total

1.  Sequential induction of beta cell rest and stimulation using stable GIP inhibitor and GLP-1 mimetic peptides improves metabolic control in C57BL/KsJ db/db mice.

Authors:  Varun Pathak; Srividya Vasu; Victor A Gault; Peter R Flatt; Nigel Irwin
Journal:  Diabetologia       Date:  2015-06-06       Impact factor: 10.122

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.